Una alternativa a l’\u00fas d’antibi\u00f2tics creada pel grup del Dr. Rafael Ma\u00f1ez, de l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l’Hospital Universitari de Bellvitge (HUB), ha estat seleccionada pel programa CaixaImpulse Consolidate. El projecte rebr\u00e0 una ajuda de fins a 300.000 euros i acompanyament personalitzat en el proc\u00e9s de transfer\u00e8ncia al mercat. Aquest projecte presenta un f\u00e0rmac alternatiu als antibi\u00f2tics que permet atacar les infeccions hospital\u00e0ries. Les resist\u00e8ncies a antibi\u00f2tics que desenvolupen alguns bacteris s\u00f3n un greu problema sanitari, i causen fins a 25.000 mort a l’any nom\u00e9s a Europa. Aquest f\u00e0rmac permetria atacar aquestes infeccions evitant la generaci\u00f3 de noves resist\u00e8ncies.<\/p>\n
L’equip del Dr. Ma\u00f1ez ha dissenyat un nou f\u00e0rmac que estimula el sistema immunitari perqu\u00e8 aquest ataqui de manera m\u00e9s efica\u00e7 els bacteris Gram-, els m\u00e9s comuns en infeccions hospital\u00e0ries. El f\u00e0rmac s’uneix de manera espec\u00edfica als anticossos no neutralitzants que crea el nostre cos. Com que no est\u00e0 actuant directament contra els bacteris, aquests no generaran resist\u00e8ncia contra el nou f\u00e0rmac. Aquest projecte ja ha atret l’atenci\u00f3 d’inversors, i l’abril del 2018 es va crear, al voltant d’aquest producte, la spin-off de l\u2019IDIBELL RemAb Therapeutics.<\/p>\n
El programa CaixaImpulse va ser creat fa 5 anys amb l\u2019objectiu de facilitar el trasllat a la societat del coneixement cient\u00edfic. Fina ara, aquest programa constava de les convocat\u00f2ries Validate, que pretenien impulsar la transfer\u00e8ncia tecnol\u00f2gica de projectes que tot just comen\u00e7aven. Aquest any ha estat el primer de les convocat\u00f2ries Consolidate, el qual pret\u00e9n acompanyar projectes m\u00e9s madurs fins a la seva implantaci\u00f3 en el mercat.<\/p>\n
En la primera edici\u00f3 de les convocat\u00f2ries Consolidate, s’hi van presentar fins a 35 sol\u00b7licituds, i despr\u00e9s d’un intens proc\u00e9s de selecci\u00f3, en el qual han participat experts cient\u00edfics i del m\u00f3n de la innovaci\u00f3, quatre han estat els projectes seleccionats: Una prova de diagn\u00f2stic per personalitzar la ter\u00e0pia contra el c\u00e0ncer (Vall d’Hebr\u00f3n Institut Oncol\u00f2gic, VHIO), una tecnologia avan\u00e7ada d’edici\u00f3 gen\u00e8tica pel tractament de malalties (Universitat Pompeu Fabra, UPF), una ter\u00e0pia g\u00e8nica contra l’at\u00e0xia de Friedreich (Fundaci\u00f3 Institut de Recerca Germans Trias i Pujol), i el projecte del Dr. Ma\u00f1ez.<\/p>\n","protected":false},"excerpt":{"rendered":"
Una alternativa a l’\u00fas d’antibi\u00f2tics creada pel grup del Dr. Rafael Ma\u00f1ez, de l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l’Hospital Universitari de Bellvitge (HUB), ha estat seleccionada pel programa CaixaImpulse Consolidate. El projecte rebr\u00e0 una ajuda de fins a 300.000 euros i acompanyament personalitzat en el proc\u00e9s de transfer\u00e8ncia al mercat. Aquest projecte presenta […]<\/p>\n","protected":false},"author":6,"featured_media":10364,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[374,493,334],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-09 16:20:57","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7320"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=7320"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7320\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/10364"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=7320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=7320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=7320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}